ADMEcell- New Technology For Transporting Cell Based Assays

Posted by Sandy Koshkin on Thu, Apr 12, 2012 @ 05:08 PM

Ready-to-Use Cell-Based Assays 

The Cell-Based Assay market is projected to continue double digit growth over the next several years. One of the major challenges facing the development and manufacturing of Cell based assay products for drug discovery and development is the difficulty associated with preserving the cells and the integrity of cell junctions during the transportation and storage of the finished kits. There are numerous Cell based assay Kits available such as cell viability and proliferation.  Caco Monolayer

A unique proprietary  shipping medium has been introduced by ADMEcell that allows for selected cell based assay kits to be shipped in a solid state at room temperature.  Once the kits are received, the shipping medium is simply removed by liquefaction at 37oC, and replaced with a fresh medium.  The cells are then ready for use in the assay for experimental compounds soon after.

Cell Based Assays such as Caco-2, MDCK and BCRP benefit from this innovative technology. ADMEcell’s  Ready-To-Use  Cell Based Assay Kits- Ready-to-Use Cell-Based Assays - are shipped at room temperature on a regular basis, providing a unique and convenient tool for accelerating the drug discovery and development process.

As the Cell Based Assay market continues to grow,  availability of a shipping medium that allows for shipping Ready-To-Use Cell Based products  at room temperature will have a major impact on the availability of the kits that would not have been readily available otherwise.

Tags: Ready To Use Assays, Ready To Use Kits, caco-2 assay, cell based assays, Drug Transporter studies

CellBased Assays Market-Looking Forward to 2012 and Beyond

Posted by Sandy Koshkin on Fri, Jan 06, 2012 @ 01:52 PM

ADMEcell – 2012 and Beyond

ADMEcell experienced a successful 2011 with the increase in the sales of  cell-based assays product line. Cell-based assays continue to be in great demand for large and small pharma companies, biotech companies and research institutions.  ADMEcell has recently introduced a ready-to-use cell-based assay for BCRP for drug transporter studies. The BCRP kit fits very well with the ready-to-use ADMEcell Caco-2 and MDCK-MDR-1 kits. The Caco-2 kit has been adapted by numerous biotech companies for their drug development programs. The poster presented  by Celgene at the recent AAPS shows how successfully they have adapted the ADMEcell CacoReady kit to their drug discovery program:Caco-2 Monolayer

 http://www.admecell.com/download-the-aaps-cacoready-poster

The cell-based assay market continues to grow at a rate of 10% per year. Almost all of this market is from assays generated in-house at various companies and institutions. The market to provide ready-to-use cell-based assays is just beginning to take off as companies look for sourcing state of the art and ready-to-use assays to assist them in drug discovery and development programs.

ADMEcell continues to add new in vitro models including cell-based assays to its product portfolio.  A cell-based assay for  blood Brain Barrier holds much promise as a new model to adapt.

ADMEcell’s new research facility has been completed and current development projects are under way to expand ADMEcell’s product line in the preclinical development field. New assays will focus on saving time and increasing accuracy to assist the drug discovery and development process.

Tags: cell based assays, Drug Transporter studies